
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32528462</article-id><article-id pub-id-type="pmc">7247839</article-id><article-id pub-id-type="doi">10.3389/fimmu.2020.00650</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Cell-in-Cell Structures in the Liver: A Tale of Four E&#x02019;s</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Davies</surname><given-names>Scott P.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/488915/overview"/></contrib><contrib contrib-type="author"><name><surname>Terry</surname><given-names>Lauren V.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/827785/overview"/></contrib><contrib contrib-type="author"><name><surname>Wilkinson</surname><given-names>Alex L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/921809/overview"/></contrib><contrib contrib-type="author"><name><surname>Stamataki</surname><given-names>Zania</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/408400/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><sup>2</sup><institution>NIHR Birmingham Liver Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Florence Niedergang, Centre National de la Recherche Scientifique (CNRS), France</p></fn><fn fn-type="edited-by"><p>Reviewed by: Luis Enrique Munoz, University of Erlangen-Nuremberg, Germany; Jean-pierre Couty, Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale (INSERM), France</p></fn><corresp id="c001">*Correspondence: Zania Stamataki, <email>z.stamataki@bham.ac.uk</email></corresp><fn fn-type="other" id="fn004"><p>This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><elocation-id>650</elocation-id><history><date date-type="received"><day>03</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Davies, Terry, Wilkinson and Stamataki.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Davies, Terry, Wilkinson and Stamataki</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The liver is our largest internal organ and it plays major roles in drug detoxification and immunity, where the ingestion of extracellular material through phagocytosis is a critical pathway. Phagocytosis is the deliberate endocytosis of large particles, microbes, dead cells or cell debris and can lead to cell-in-cell structures. Various types of cell endocytosis have been recently described for hepatic epithelia (hepatocytes), which are non-professional phagocytes. Given that up to 80% of the liver comprises hepatocytes, the biological impact of cell-in-cell structures in the liver can have profound effects in liver regeneration, inflammation and cancer. This review brings together the latest reports on four types of endocytosis in the liver -efferocytosis, entosis, emperipolesis and enclysis, with a focus on hepatocyte biology.</p></abstract><kwd-group><kwd>cell-in-cell</kwd><kwd>liver</kwd><kwd>efferocytosis</kwd><kwd>entosis</kwd><kwd>emperipolesis</kwd><kwd>enclysis</kwd><kwd>cancer</kwd><kwd>regeneration</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Wellcome Trust<named-content content-type="fundref-id">10.13039/100004440</named-content></funding-source></award-group><award-group><funding-source id="cn002">Medical Research Council<named-content content-type="fundref-id">10.13039/501100000265</named-content></funding-source></award-group><award-group><funding-source id="cn003">National Centre for the Replacement Refinement and Reduction of Animals in Research<named-content content-type="fundref-id">10.13039/501100010757</named-content></funding-source></award-group><award-group><funding-source id="cn004">Royal Society of Biology<named-content content-type="fundref-id">10.13039/100012361</named-content></funding-source></award-group></funding-group><counts><fig-count count="5"/><table-count count="1"/><equation-count count="0"/><ref-count count="101"/><page-count count="10"/><word-count count="0"/></counts></article-meta></front><body><sec id="S1"><title>Introduction</title><p><italic>Cell-in-cell</italic> (CIC) structures are formed when a whole cell resides inside the cytoplasm of another, and they have been observed for decades in various contexts. The best characterized CIC mechanism is known as <italic>efferocytosis</italic>, the clearance of dead or dying cells by professional and non-professional phagocytes (<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B9" ref-type="bibr">9</xref>). Yet, CIC structures, in which the internalized cell remains viable, have been observed for over a century (<xref rid="B10" ref-type="bibr">10</xref>). Recent work has provided evidence for the role of hepatocytes, the principal parenchymal cell within the liver, in several of these processes: <italic>efferocytosis</italic> (<xref rid="B1" ref-type="bibr">1</xref>), live cell internalization events including <italic>suicidal emperipolesis</italic> (<xref rid="B11" ref-type="bibr">11</xref>), <italic>entosis</italic> (<xref rid="B12" ref-type="bibr">12</xref>) and <italic>enclysis</italic> (<xref rid="B13" ref-type="bibr">13</xref>) (<xref rid="T1" ref-type="table">Table 1</xref>). Although the immediate consequences of dead and live cell capture have been investigated, the biological implications and impact on clinical outcomes remain to be elucidated.</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>The mechanism of cell-in-cell structures.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><tbody><tr><td valign="top" align="justify" rowspan="1" colspan="1"><inline-graphic xlink:href="fimmu-11-00650-t001.jpg"/></td></tr></tbody></table><table-wrap-foot><attrib><italic>The best-characterized process is efferocytosis, where multiple receptors have been identified, however, only one receptor is known for hepatocytes (ASGR1). Receptors unique to entosis, emperipolesis or enclysis have not been identified.</italic></attrib></table-wrap-foot></table-wrap><p>The liver receives 75% of its blood supply from the gastrointestinal tract via the hepatic portal vein (<xref rid="B14" ref-type="bibr">14</xref>). As such, it is persistently challenged by toxic substances and microbial- or food-derived antigens. Not only must the liver function to detoxify and neutralize harmful products it is exposed to, it must also maintain an immunotolerising environment so as not to initiate inappropriate immune responses to commensal microbes and food antigens. Nonetheless, the liver must retain the ability to mount a rapid immune response in the case of infection. The role of the liver in immunity is well-established (<xref rid="B15" ref-type="bibr">15</xref>), and the cells residing within it are finely tuned to maintain the balance between immunotolerance and immunogenicity. If this balance is perturbed and tolerance is breached, liver disease can develop due to hepatocyte damage during inflammation.</p><p>Chronic liver diseases follow a common pathway of progression independently of etiology. Repeated liver injury results in fibrosis, cirrhosis and ultimately, end-stage disease leading to liver failure, the only viable treatment option for these patients is liver transplantation, which is associated with significant pitfalls including organ shortage and graft rejection. Since liver disease continues to increase worldwide (<xref rid="B16" ref-type="bibr">16</xref>) there is an unmet clinical need to develop novel therapies that will alleviate chronic inflammation, prevent fibrosis or boost liver immunity in the context of viral infection and primary or metastatic liver cancer. Hepatocytes constitute an attractive target for therapy in these patients, because (i) they are uniquely found in the liver, (ii) they drive regeneration in injury, (iii) they are the focus of infection or malignancy in hepatocellular carcinoma, (iv) they are a natural destination for drug absorption, and (v) unlike targeting immune cells, hepatocyte-directed therapies are unlikely to cause systemic immunosuppression or autoimmunity. We propose that targeting CIC structures has the potential to lead to clinical benefit for patients with liver diseases.</p></sec><sec id="S2"><title>Efferocytosis</title><p>The capture and deletion of dying cells by <italic>efferocytosis</italic> (from <italic>effere</italic>, Latin for &#x0201c;to take to the grave,&#x0201d; &#x0201c;to bury&#x0201d;), a specialized form of phagocytosis, is a crucial process for the liver with important biological impact (<xref rid="B1" ref-type="bibr">1</xref>). The liver is inundated with infiltrating immune cells that are destined to die by apoptosis and be digested by liver cells (<xref rid="B17" ref-type="bibr">17</xref>). The frequent turnover of hepatocytes, associated with the detoxification of waste products, further contributes to the dead cell burden faced by the liver. Failure to clear these cell corpses can spell disastrous immune consequences, including premature inflammatory responses and an increased risk of autoimmune disease (<xref rid="B8" ref-type="bibr">8</xref>).</p><p>To prevent the build-up of cellular debris, the cellular composition of the liver is uniquely prepared, it is frequented by monocyte-derived macrophages and possesses a specialized resident macrophage population known as Kupffer cells, which arise following signals from liver-resident cells (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B18" ref-type="bibr">18</xref>). Aside from these &#x0201c;professional phagocytes,&#x0201d; liver- parenchymal and non-parenchymal cells can also capture and delete dying cells. These &#x0201c;non-professional&#x0201d; populations include hepatic sinusoidal endothelial cells (HSECs), biliary epithelial cells (BECs), stellate cells and hepatocytes (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). As such, the liver is universally prepared to rapidly clear cell corpses, thus maintaining its immune tolerance.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Hepatocytes are important efferocytes. Comprising up to 80% of the liver mass, hepatocytes engulf apoptotic and necrotic cells via the asialoglycoprotein receptor (ASGR1) (<xref rid="B3" ref-type="bibr">3</xref>), and rapidly degrade them. This process may supply the liver with nutrients while maintaining homeostasis by eliminating pro-inflammatory cell debris. CIC structures can also lead to failure of cytokinesis (<xref rid="B19" ref-type="bibr">19</xref>) and this can impact hepatocyte ploidy.</p></caption><graphic xlink:href="fimmu-11-00650-g001"/></fig><p>An astute adaptation of the liver to manage the persisting need to clear dying cells is for its principal cell type, the hepatocyte, to be adept at efferocytosis (<xref rid="B1" ref-type="bibr">1</xref>). Hepatocytes are epithelia tasked with drug detoxification and can undergo necrotic cell death in the process, thus neighboring hepatocytes are most likely to make first contact with a dying cell. Hepatocyte efferocytosis was first described in 1952, when Rosin and colleagues observed the presence of erythrocytes within the cytoplasm of hepatocytes (<xref rid="B2" ref-type="bibr">2</xref>). This was later ratified by Dini et al., who showed that hepatocytes could also engulf apoptotic cells (<xref rid="B3" ref-type="bibr">3</xref>). The same investigation suggested a role for asialoglycoprotein receptor 1 (ASGR1) in the recognition of these cells. Experiments conducted in our group has further confirmed hepatocyte ability to engulf necrotic cells in health and in cancer (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B13" ref-type="bibr">13</xref>). Other cells which have this capability generally require alternative, more improvisational molecular mechanisms to capture necrotic cells, compared to those known for apoptotic cell capture (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B20" ref-type="bibr">20</xref>). Hepatocytes can both remove and replenish areas of necrotic sheets associated with disease-related hepatotoxicity, and drive regeneration during injury (<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>).</p><p>In contrast to the liver&#x02019;s professional phagocyte populations, the mechanisms by which hepatocytes clear dead cells are poorly understood. There are few candidate receptors, in addition to ASGR1, by which hepatocytes may recognize and capture dying cells. The consequences of efferocytosis for the hepatocyte have also not been widely explored. The hepatocyte would be granted nutrients from the lysosomal digestion of captured cells. Hepatocytes may also acquire increased genetic diversity at the cellular level through efferocytosis. Efferosomes may physically impede cytokinesis, causing the engulfing hepatocyte to become multinucleate, as seen in breast cancer cells with CIC structures (<xref rid="B12" ref-type="bibr">12</xref>). Increased genetic diversity amongst hepatocytes has been shown to increase the ability of the liver to adapt and regenerate in response to a wider variety of insults (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Efferocytosis may be a mechanism which accelerates this phenomenon, although this may also increase the risk of contracting mutations associated with the onset of hepatocellular carcinoma (HCC). Although hepatocyte multinucleation is both frequent and tolerated in the liver, particularly in older individuals (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>), chronic efferocytosis resulting from disease-associated necrosis may promote the acquisition of oncogenic mutations. As the onset of HCC is rarely spontaneous and frequently associated with chronic liver disease, increased hepatocyte efferocytosis may represent a risk factor for its onset.</p><p>Dysregulation of efferocytosis in the liver can lead to disease development. This has been exemplified in the case of macrophage clearance, knockout mice lacking hepatic macrophages that express the dead cell scavenger receptor, MerTK, showed exasperated damage when treated with acetaminophen (APAP) (<xref rid="B28" ref-type="bibr">28</xref>). More recently it was demonstrated that carbon tetrachloride-treated glycoprotein NMB (gpnmb) KO mice, whose macrophages lack the ability to process internalized cells, showed greater activation of pro-fibrotic myofibroblasts (<xref rid="B29" ref-type="bibr">29</xref>). It is also likely that the dysregulation of hepatocyte efferocytosis may contribute to the pathogenesis of other chronic liver diseases. Autoantibodies against ASGR1 have been detected in patients with autoimmune hepatitis (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). Additionally, ethanol-treated rat hepatocytes were shown to be defective in ASGR1-mediated efferocytosis (<xref rid="B32" ref-type="bibr">32</xref>).</p><p>The effects of aging and the accompanying immune paresis must be considered in liver homeostasis, specifically regarding the clearance of apoptotic and necrotic cells. In both aging and chronic liver disease, there is an accumulation of senescent cells, which produce senescence-associated secretory phenotype (SASP) factors. SASP factors include pro-inflammatory cytokines and growth factors, that have been noted to alter the local microenvironment and induce paracrine senescence and in turn, immuno senescence (<xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B35" ref-type="bibr">35</xref>). One characteristic of immune senescence is the reduced capacity of a cell to phagocytose, which may contribute to persistent inflammation in older individuals, termed &#x0201c;inflammageing&#x0201d; and lead to defective clearance and resolution of inflammation (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>).</p><p>Whilst little is understood about hepatocyte efferocytosis in terms of aging, several <italic>in vivo</italic> studies have shown an age-associated decline in macrophage efferocytosis in other tissue types. For example, one study observed that peritoneal macrophages from aged (24-month old) mice had an impaired ability to efferocytose apoptotic Jurkat cells, compared to 2-month old, young mice (<xref rid="B38" ref-type="bibr">38</xref>). This result was similarly observed by Linehan et al., whom proceeded to transplant young (8 to 12-week-old mice) peritoneal macrophages into aged (15 to 20-month-old mice) peritoneal space (<xref rid="B39" ref-type="bibr">39</xref>). The transplanted, young macrophages in fact exhibited a diminished ability to efferocytose post-transplantation, suggesting that the microenvironment lead to alterations in the efferocytic ability. Additionally, there was a decline in the ability of alveolar macrophages to efferocytose neutrophils in aged mice, which may contribute to lung damage (<xref rid="B40" ref-type="bibr">40</xref>). Based on links drawn between diminished efferocytic capacity and old age, it is logical to infer that hepatocytes could be subjected to similar pressures from aging and this warrants further investigation.</p><p>Further understanding into the mechanisms of hepatocyte efferocytosis will likely provide opportunities for promoting dead cell clearance and thus preventing immature inflammatory responses in the liver.</p></sec><sec id="S3"><title>Entosis</title><p>For over a century, CIC structures in which viable cells are internalized into other cells have been reported (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>). Live cells have been shown to invade or be engulfed by host cells of non-phagocytic origin. Unlike with efferocytosis, which consistently targets cell corpses for lysosomal degradation, these cells can remain viable within vacuole-like structures for long periods and succumb to variable outcomes depending on the context. Although the molecular mechanisms for most examples of live CIC formation generally remain poorly understood, several processes are well-described in the literature. One of these is known as <italic>entosis</italic> (&#x003b5;&#x003bd;&#x003c4;&#x000f3;&#x003c2;, inside, into, within) (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B43" ref-type="bibr">43</xref>).</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Entosis in neoplastic hepatocytes. We recently showed that hepatocellular carcinoma cells were able to engulf their live neighbors by entosis (<xref rid="B13" ref-type="bibr">13</xref>). Entosis is an important disease pathway in cancer epithelia involving E-cadherin and &#x003b2;-catenin (<xref rid="B12" ref-type="bibr">12</xref>). Tumor cells that detach from matrix are prone to entosis, and further research is necessary to measure its implications in patients with hepatocellular carcinoma.</p></caption><graphic xlink:href="fimmu-11-00650-g002"/></fig><p>In 2007, Overholtzer and colleagues reported that extracellular matrix detachment of cancer cells could promote CIC formation via contractile forces associated with adherens junction formation. This process involved junctional proteins, E-cadherin and &#x003b2;-catenin, and was dependent on actomyosin contractility mediated by Rho-associated coiled-coil-containing protein kinase (ROCK) activity in the target cell specifically (<xref rid="B12" ref-type="bibr">12</xref>). This finding, coupled with time-lapse microscopy of CIC formation, was strongly suggestive of target cell invasion as opposed to engulfment and has since been confirmed in several studies (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>).</p><p>The plasma membrane is the primary site for initiating CIC formation. Plasma membrane blebbing and polarized actin dynamics have been suggested as drivers of entotic invasion (<xref rid="B45" ref-type="bibr">45</xref>), with a recent study demonstrating the requirement for the myocardin-related transcription factor-serum response factor (MRTF-SRF) pathway and subsequent sustained ezrin-dependent plasma membrane blebbing (<xref rid="B44" ref-type="bibr">44</xref>). Furthermore, in addition to the requirement for adherens junctions (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>), studies have shown that the composition of the plasma membrane play a role in entosis. Both liposomes and cholesterol were shown to inhibit CIC formation, presumably by hindering myosin light chain phosphorylation and thus actomyosin contractility (<xref rid="B48" ref-type="bibr">48</xref>).</p><p>The fate of the internalized cell is variable, most succumb to non-apoptotic cell death and lysosomal degradation, although some target cells occasionally undergo division or release (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B49" ref-type="bibr">49</xref>&#x02013;<xref rid="B51" ref-type="bibr">51</xref>). Thus, the biological consequences of entosis and the impact on tumor biology remain controversial (<xref rid="B52" ref-type="bibr">52</xref>). Since degradation of target cells by neighboring cancer cells has the potential to limit tumor growth, then perhaps entosis represents an intrinsic tumor suppressor mechanism, by which metastatic cancer cells that become detached from matrix are eliminated. Yet, adherent epithelial cells can also undergo entosis, a process driven by mitosis and negatively regulated by cell cycle protein Cdc42 (<xref rid="B46" ref-type="bibr">46</xref>). Furthermore, tumor cell cannibalism could promote host cell survival by providing nutrients to those which lack vascular access (<xref rid="B53" ref-type="bibr">53</xref>). In support of this, Overholtzer&#x02019;s group later demonstrated that entosis is induced in adherent cells by glucose starvation, in a manner requiring activity of target cell AMP-activated protein kinase (AMPK) (<xref rid="B54" ref-type="bibr">54</xref>). The ability of cancer cells to adapt to starvation by performing entosis and enabling nutrient recovery would confer metabolic advantage of malignant cells, thereby promoting progression of more aggressive tumors. Indeed, it has been proposed that there is direct competition between cancer cells, dictated by mechanical deformability and subsequent entosis, thus ensuring the survival of the most adapted tumor cells (<xref rid="B55" ref-type="bibr">55</xref>). These findings highlight the importance of the tumor microenvironment in regulating intracellular signaling pathways that mediate entosis and tumor survival.</p><p>The clinical impact of entosis in hepatocellular carcinoma has not been investigated. Similarly to observations made in other epithelial cells, we reported recently that hepatomas cultured in 2D were also capable of engulfing their neighbors (<xref rid="B13" ref-type="bibr">13</xref>). The vesicle that housed the internalized cell was enriched in E-cadherin, suggesting that this was another example of entosis (<xref ref-type="fig" rid="F2">Figure 2</xref>). It is not yet clear if non-neoplastic hepatocytes perform entosis. Regardless, liver cancers may benefit from entosis as a source of adaptation and nutrition. Given that there is no effective therapy and the incidence of hepatocellular carcinoma is increasing in the West (<xref rid="B56" ref-type="bibr">56</xref>), targeting entosis may prove to be of clinical value.</p></sec><sec id="S4"><title>Emperipolesis</title><p><italic>Emperipolesis</italic> is a term coined by Humble et al. (<xref rid="B57" ref-type="bibr">57</xref>) and used to describe the movement of live cells following internalization (&#x0201c;inside-round-about wandering&#x0201d;) (<xref ref-type="fig" rid="F3">Figure 3</xref>) (<xref rid="B57" ref-type="bibr">57</xref>). It has been proposed that whilst CIC and emperipolesis should be used generically to describe the process of cell movement associated with CIC structures, cannibalism and entosis should be used to refer to mechanisms of CIC formation specifically (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Cell-in-cell structures, or emperipolesis, have long been observed by histopathologists in several types of chronic liver disease. Emperipolesis is increased in autoimmune hepatitis (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>) and chronic viral infection (<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>), suggesting a potential role in liver injury or T cell clearance (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>). The precise physiological and pathophysiological role of emperipolesis, however, remains elusive.</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Suicidal Emperipolesis. The seminal work by Benseler et al. provided the first evidence for a biological role of the cell-in-cell structures described as emperipolesis, where immune cells were engulfed alive by hepatocytes (<xref rid="B11" ref-type="bibr">11</xref>). In this study, autoreactive CD8<sup>+</sup> T cells were deleted by suicidal emperipolesis in the liver. The mechanism of capture is not understood, however, perturbation of this process led to breach of liver tolerance in mice.</p></caption><graphic xlink:href="fimmu-11-00650-g003"/></fig><p>The first demonstration of a physiological role for emperipolesis in the liver was reported by Bertolino and colleagues in 2011. They defined a mechanistically distinct type of emperipolesis known as <italic>suicidal emperipolesis</italic>, in which autoreactive CD8<sup>+</sup> T lymphocytes actively invade hepatocytes and undergo lysosomal degradation (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B64" ref-type="bibr">64</xref>). Inhibition of this process by wortmannin led to intrahepatic accumulation of autoreactive cells and a breach of tolerance. Wortmannin-treated mice developed immune-mediated hepatitis 3 days post-infusion with autoreactive CD8<sup>+</sup> T cells, as determined by raised alanine aminotransferase levels and histological liver damage. The authors therefore proposed this as a mechanism of extrathymic regulation for maintaining immune tolerance within the liver.</p><p>There is also evidence for a pathophysiological role of CIC structures. <italic>Emperitosis</italic>, another form of emperipolesis, was the name initially given to natural killer (NK) cell invasion of tumor cells and subsequent programmed cell death. Like entosis, emperitosis also requires cadherins, Rho/ROCK proteins and ezrin (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>). In contrast to entosis, NK cells succumb to caspase-3-mediated apoptosis, which was attributed to granzyme B accumulation within the vacuole (<xref rid="B65" ref-type="bibr">65</xref>). This process has also been extended to human cytotoxic regulatory T cell line, HOZOT, which actively penetrate cancer cell lines but not cells of non-neoplastic origin (<xref rid="B67" ref-type="bibr">67</xref>). It is therefore conceivable that emperitosis of cytotoxic immune cells serves as one of the many mechanisms employed by cancer cells to evade immune surveillance. Furthermore, a recent study showing that internalization of anti-fibrotic NK cells in HBV cirrhotic patients is transforming growth factor-&#x003b2;-dependent and may represent a novel mechanism of fibrogenesis (<xref rid="B68" ref-type="bibr">68</xref>). Further work is required to fully elucidate the molecular mechanisms of suicidal emperipolesis, which may allow therapeutic targeting in the context of liver transplantation, autoimmune disease and viral hepatitis. Nevertheless, the evidence that this process is distinct from other CIC mechanisms is compelling, and is one example of the complex pathways which can underlie CIC formation.</p></sec><sec id="S5"><title>Enclysis</title><p>We have recently reported a distinct cell capture process within the liver termed <italic>enclysis</italic> (<inline-formula><mml:math id="INEQ3"><mml:mrow><mml:mtext>E</mml:mtext><mml:mo>&#x02062;</mml:mo><mml:mi mathvariant="normal">&#x003b3;</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi mathvariant="normal">&#x003ba;</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi mathvariant="normal">&#x003bb;</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x02062;</mml:mo><mml:mi mathvariant="normal">&#x003c9;</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mover accent="true"><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mo>&#x000b4;</mml:mo></mml:mover><mml:mo>&#x02062;</mml:mo><mml:mi mathvariant="normal">&#x003b3;</mml:mi></mml:mrow></mml:math></inline-formula>- (<inline-formula><mml:math id="INEQ4"><mml:mover accent="true"><mml:mi mathvariant="normal">&#x003b5;</mml:mi><mml:mo>&#x000b4;</mml:mo></mml:mover></mml:math></inline-formula>v-) + &#x003ba;&#x003bb;&#x003b5;&#x003c9;, to enclose, to confine, to keep in captivity), in which live CD4<sup>+</sup> T cells are captured by hepatocytes (<xref ref-type="fig" rid="F4">Figure 4</xref>) (<xref rid="B13" ref-type="bibr">13</xref>). This process occurred <italic>in vitro</italic>, in primary human hepatocytes and in hepatoma cells (Huh-7 and HepG2 cells), and <italic>ex vivo</italic> within patient liver samples. T cells were also found to reside within hepatocytes <italic>in vivo</italic> as shown in 30 &#x003bc;m-thick sections from cirrhotic patients.</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>Enclysis in health and in hepatocellular carcinoma. Enclysis is the enclosure and lysis of regulatory T cells (Treg) by hepatocytes and hepatocyte cancer cells (<xref rid="B13" ref-type="bibr">13</xref>). We showed that Treg cells were captured preferentially compared to non-regulatory CD4<sup>+</sup> T cells, and also suffered a different fate, as non-regulatory T cells often survived hepatocyte entry.</p></caption><graphic xlink:href="fimmu-11-00650-g004"/></fig><p>Whilst intercellular adhesion molecule-1 (ICAM-1) facilitated early T cell adhesion to hepatocytes, the ligands for ICAM-1 are not distinct to CD4<sup>+</sup> T cells and therefore this adhesion molecule does not explain enclysis specificity. Interestingly, adhesion molecule and junctional protein, &#x003b2;-catenin, selectively associated with the enclytic vesicle, in contrast to the efferosome (phagosome containing dead cell) which showed no &#x003b2;-catenin localization. Despite both entosis and enclysis involving formation of membrane blebs (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>), enclysis was distinguished from entosis by the lack of E-cadherin association with the enclytic vesicle. Notably, instances of entosis were observed between Huh-7 hepatoma cells, where a clear localization of E-cadherin was apparent. The lack of requirement for the RhoA/ROCK pathway, similar to suicidal emperipolesis, provides a further distinction of enclysis and entosis. Enclysis resembles macropinocytosis, in that there are significant membrane alterations during cell capture events including ruffling, blebs and lamellipodia formation (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B69" ref-type="bibr">69</xref>), which is in contrast to emperipolesis where these membrane protrusions are absent (<xref rid="B63" ref-type="bibr">63</xref>). Furthermore, the wortmannin-insensitivity of enclysis further defines this process as mechanistically distinct, compared with emperipolesis which is abrogated by wortmannin treatment (<xref rid="B11" ref-type="bibr">11</xref>).</p><p>Whilst CD4<sup>+</sup> T cells were specifically targeted over CD8<sup>+</sup> T cells and CD20<sup>+</sup> B cells, Tregs were three times more likely to be engulfed than non-Treg cells. Vesicles containing Tregs readily acidified with cells undergoing degradation via the lysosomal pathway, unlike non-Tregs, which survived for long periods and remained connected to the extracellular space via the endocytic pathway. Moreover, FOXP3<sup>+</sup> Tregs were more frequently found within hepatocytes than Tbet<sup>+</sup> effector cells, in both donor livers surplus to clinical requirement and liver explants from end-stage disease patients (<xref rid="B13" ref-type="bibr">13</xref>). Thus, we propose enclysis as a novel immunomodulatory pathway within the liver that could offer therapeutic opportunities to toggle inflammation. But why would hepatocytes possess the ability to target Tregs for degradation when an integral function of the liver is to maintain immunotolerance? Although this seems counter-intuitive, given the previous studies which have evidenced a role for the liver in maintaining peripheral immune tolerance (<xref rid="B70" ref-type="bibr">70</xref>), it is conceivable that enclysis could act as a biological switch, preventing the liver from becoming &#x0201c;immunoblind&#x0201d;. The ability of hepatocytes to control local T cell populations and modulate ratios of regulatory and effector cells may represent an intrinsic mechanism by which the liver can rapidly respond to its local inflammatory environment. The stimuli and endogenous regulators of enclysis, however, are yet to be defined.</p><p>Identification of selective modulators of enclysis may offer opportunities for therapeutic intervention. On one hand, inhibition of Treg cell capture and/or degradation may be successful in situations where it is desirable to enrich local Treg populations and dampen inflammation. Indeed, research surrounding Treg cell-based therapy is ongoing (<xref rid="B71" ref-type="bibr">71</xref>&#x02013;<xref rid="B75" ref-type="bibr">75</xref>), and combination with pharmacological inhibitors of enclysis may show promise for several indications, including chronic inflammation and to promote immunotolerance following organ transplantation. Alternatively, in the context of cancer, boosting Treg sequestration or modulating release of effector T cell subsets may be beneficial to enhance tumor immunogenicity (<xref rid="B76" ref-type="bibr">76</xref>).</p></sec><sec id="S6"><title>Implications and Future Perspectives</title><p>The impact of cell-in-cell structures on the host cell biology has only recently been investigated. Phagocytosed cells that enter the phagocyte as apoptotic cells or cellular debris, and also engulfed live cells that may subsequently die inside endosomes, can present an added source of nutrients. However, CIC may have longer-lasting implications on the host cell.</p><p>Consequences of viable cell internalization include eventual death of host or target cells, target cell division or release, or prevention of host cell division which can cause multinucleation, polyploidy and aneuploidy (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B77" ref-type="bibr">77</xref>). This has implications for cancer metastatic potential (<xref rid="B78" ref-type="bibr">78</xref>), and links between aneuploidy and genomic instability (loss of tumor suppressor genes) have been established (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B77" ref-type="bibr">77</xref>). A recent study has shown that p53 mutations in lung adenocarcinoma patients are associated with increased incidence of cell-in-cell structures, and that mutant p53 expression promotes entotic engulfment, tumorigenesis and disease recurrence (<xref rid="B51" ref-type="bibr">51</xref>). Whilst host cells lacking p53 had perturbed cell division and subsequent death, mutant p53 cells underwent aberrant cell division, multinucleation, and tripolar mitosis. Thus, p53 expression facilitated pro-tumorigenic entotic engulfment and abnormal mitosis, which consequently contributed to genomic instability.</p><p>Cell-in-cell structures in patients are indicative of worse clinical grade and poor prognosis (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B79" ref-type="bibr">79</xref>). In the context of the liver, ploidy changes and multinucleation in hepatocytes are important considerations for liver regeneration (<xref rid="B25" ref-type="bibr">25</xref>&#x02013;<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B80" ref-type="bibr">80</xref>&#x02013;<xref rid="B82" ref-type="bibr">82</xref>) and associate with various pathological processes (<xref rid="B83" ref-type="bibr">83</xref>). In a study where oxidative stress was shown to promote polyploidy in non-alcoholic fatty liver disease, the authors suggested that hepatocyte multinucleation preceded the onset of hepatocellular carcinoma (<xref rid="B84" ref-type="bibr">84</xref>). In the absence of cancer, it is now understood that the polyploid state in mice may restrict hepatocyte proliferation and liver regeneration (<xref rid="B81" ref-type="bibr">81</xref>).</p><p>It is important to consider the biological impact of cell-in-cell structures in liver diseases. Hepatocytes have evolved to eliminate apoptotic and necrotic cells efficiently to prevent inflammation, and this is also true for other CIC processes, the mechanisms of cell death in the liver have been described previously (<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>). Failure to eliminate necrotic or autoreactive cells would exacerbate liver injury and increase the incidence of fibrosis. Fibrosis (liver scarring) is the consequence of various chronic liver diseases caused by viral, autoimmune, metabolic or cholestatic liver injury, and can lead to cirrhosis and end-stage disease requiring a transplant. The precise mechanism of bile acid hepatotoxicity has not been fully elucidated.</p><p>Non-alcoholic fatty liver disease (NAFLD) is of increasing concern at a global scale, and up to 25% of patients can progress to non-alcoholic steatohepatitis (NASH). Increased liver enzymes denote hepatocellular damage [ALT, AST, and others, reviewed in (<xref rid="B86" ref-type="bibr">86</xref>)]. The molecular mechanisms controlling hepatocellular injury have begun to emerge in recent studies that revealed a role for the transcription regulator TAZ in preventing hepatocyte death, inflammation and fibrosis (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B88" ref-type="bibr">88</xref>). Further, hepatocyte Notch activation was linked directly to NASH-related fibrosis (<xref rid="B89" ref-type="bibr">89</xref>). The role of efferocytosis in the clearance of apoptotic cells and the prevention of necrotic cell injury and fibrosis in NASH has been reviewed recently (<xref rid="B90" ref-type="bibr">90</xref>).</p><p>The pro- or anti-inflammatory impact of enclysis in NASH remains to be established, however, NASH liver explants show measurable CD4<sup>+</sup> T cells inside hepatocytes, including FOXP3<sup>+</sup> and Tbet<sup>+</sup> T cells (<xref rid="B13" ref-type="bibr">13</xref>). Of note, Ma et al. showed that in NAFLD, dysregulation of lipid metabolism causes a selective loss of intrahepatic CD4<sup>+</sup> but not CD8<sup>+</sup> T cells, leading to impaired tumor surveillance and accelerated carcinogenesis (<xref rid="B91" ref-type="bibr">91</xref>). The mechanism of CD4<sup>+</sup> T cell elimination in this context has not been described, however, it was shown that T cells died by apoptosis following linoleic acid exposure from lipid-laden hepatocytes.</p></sec><sec id="S7"><title>Conclusion</title><p>The engulfment of live, apoptotic and necrotic cells by hepatocytes has important implications for their biology in health, inflammation and cancer. These range from nutrient acquisition that can promote cancer cell survival in poorly vascularized tumors, to changes in ploidy that can affect liver regeneration and cancer aggressiveness. It is therefore important to understand the molecular mechanisms that govern these processes so that they can be targeted specifically for patient benefit. <xref ref-type="fig" rid="F5">Figure 5</xref> summarizes our current knowledge of cell-in-cell structures linked to hepatocyte biology.</p><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>Cell-in-cell structures in healthy and neoplastic hepatocytes. Efferocytosis (apoptotic or necrotic cells), suicidal emperipolesis (autoreactive CD8<sup>+</sup> T cells) and enclysis (CD4<sup>+</sup> T cells, Treg) have been reported for non-neoplastic hepatocytes. Neoplastic hepatocytes can also perform efferocytosis and enclysis, and engulf fellow cancer cells that detached from matrix by entosis.</p></caption><graphic xlink:href="fimmu-11-00650-g005"/></fig><p>Increasing the clearance or necrotic cells is an important goal to prevent inflammation and liver failure, including in catastrophic drug-induced liver injury such as paracetamol (acetaminophen) toxicity. Modulation of T cell capture by suicidal emperipolesis (CD8<sup>+</sup> T cells) or enclysis (Treg cells) has the potential to influence liver tolerance and toggle inflammation in conditions such as autoimmune hepatitis, viral infection or liver cancer, where the unmet clinical needs are profound. We propose that understanding CIC structure mechanisms will enable specific therapeutic targeting and has the potential to provide new therapeutic targets for liver diseases and liver cancer.</p></sec><sec id="S8"><title>Author Contributions</title><p>LT and ZS prepared the figures. SD, LT, AW, and ZS wrote the review.</p></sec><sec id="dis1"><title>Disclaimer</title><p>The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.</p></sec><sec id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> SD was funded by an NC3R trainee fellowship. LT was funded by an MRC iCASE fellowship, and AW was funded by a Wellcome Trust Ph.D. studentship in Mechanisms of Inflammatory Diseases. This work was initiated thanks to support from a small seed award by Wellcome Trust Institutional Support Fund to ZS, who has subsequently received funding from the Medical Research Foundation (MRC), Wellcome Trust, GMG, The Birmingham Children&#x02019;s Hospital Research Foundation, and a Royal Society Dorothy Hodgkin Fellowship. This manuscript presents independent research supported by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>SP</given-names></name><name><surname>Reynolds</surname><given-names>GM</given-names></name><name><surname>Stamataki</surname><given-names>Z.</given-names></name></person-group>
<article-title>Clearance of apoptotic cells by tissue epithelia: a putative role for hepatocytes in liver efferocytosis.</article-title>
<source><italic>Front Immunol.</italic></source> (<year>2018</year>) <volume>9</volume>:<issue>44</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00044</pub-id>
<pub-id pub-id-type="pmid">29422896</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosin</surname><given-names>A</given-names></name><name><surname>Doljanski</surname><given-names>L.</given-names></name></person-group>
<article-title>Erythrocytes in the cytoplsm and nuclei of liver cells.</article-title>
<source><italic>Br J Exp Pathol.</italic></source> (<year>1944</year>) <volume>25</volume>:<fpage>111</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dini</surname><given-names>L</given-names></name><name><surname>Autuori</surname><given-names>F</given-names></name><name><surname>Lentini</surname><given-names>A</given-names></name><name><surname>Oliverio</surname><given-names>S</given-names></name><name><surname>Piacentini</surname><given-names>M.</given-names></name></person-group>
<article-title>The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor.</article-title>
<source><italic>FEBS Lett.</italic></source> (<year>1992</year>) <volume>296</volume>:<fpage>174</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">1370803</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canbay</surname><given-names>A</given-names></name><name><surname>Taimr</surname><given-names>P</given-names></name><name><surname>Torok</surname><given-names>N</given-names></name><name><surname>Higuchi</surname><given-names>H</given-names></name><name><surname>Friedman</surname><given-names>S</given-names></name><name><surname>Gores</surname><given-names>GJ.</given-names></name></person-group>
<article-title>Apoptotic body engulfment by a human stellate cell line is profibrogenic.</article-title>
<source><italic>Lab Invest.</italic></source> (<year>2003</year>) <volume>83</volume>:<fpage>655</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="pmid">12746475</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poon</surname><given-names>IK</given-names></name><name><surname>Hulett</surname><given-names>MD</given-names></name><name><surname>Parish</surname><given-names>CR.</given-names></name></person-group>
<article-title>Molecular mechanisms of late apoptotic/necrotic cell clearance.</article-title>
<source><italic>Cell Death Differ.</italic></source> (<year>2010</year>) <volume>17</volume>:<fpage>381</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2009.195</pub-id>
<pub-id pub-id-type="pmid">20019744</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Jung</surname><given-names>MY</given-names></name><name><surname>Bae</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>IS.</given-names></name></person-group>
<article-title>Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver.</article-title>
<source><italic>Blood.</italic></source> (<year>2011</year>) <volume>117</volume>:<fpage>5215</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2010-10-313239</pub-id>
<pub-id pub-id-type="pmid">21427291</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rong</surname><given-names>GH</given-names></name><name><surname>Yang</surname><given-names>GX</given-names></name><name><surname>Ando</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>XS</given-names></name><name><surname>Leung</surname><given-names>PS</given-names></name><etal/></person-group>
<article-title>Human intrahepatic biliary epithelial cells engulf blebs from their apoptotic peers.</article-title>
<source><italic>Clin Exp Immunol.</italic></source> (<year>2013</year>) <volume>172</volume>:<fpage>95</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1111/cei.12046</pub-id>
<pub-id pub-id-type="pmid">23480189</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arandjelovic</surname><given-names>S</given-names></name><name><surname>Ravichandran</surname><given-names>KS.</given-names></name></person-group>
<article-title>Phagocytosis of apoptotic cells in homeostasis.</article-title>
<source><italic>Nat Immunol.</italic></source> (<year>2015</year>) <volume>16</volume>:<fpage>907</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3253</pub-id>
<pub-id pub-id-type="pmid">26287597</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krenkel</surname><given-names>O</given-names></name><name><surname>Tacke</surname><given-names>F.</given-names></name></person-group>
<article-title>Liver macrophages in tissue homeostasis and disease.</article-title>
<source><italic>Nat Rev Immunol.</italic></source> (<year>2017</year>) <volume>17</volume>:<fpage>306</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">28317925</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Overholtzer</surname><given-names>M</given-names></name><name><surname>Brugge</surname><given-names>JS.</given-names></name></person-group>
<article-title>The cell biology of cell-in-cell structures.</article-title>
<source><italic>Nat Rev Mol Cell Biol.</italic></source> (<year>2008</year>) <volume>9</volume>:<fpage>796</fpage>&#x02013;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2504</pub-id>
<pub-id pub-id-type="pmid">18784728</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benseler</surname><given-names>V</given-names></name><name><surname>Warren</surname><given-names>A</given-names></name><name><surname>Vo</surname><given-names>M</given-names></name><name><surname>Holz</surname><given-names>LE</given-names></name><name><surname>Tay</surname><given-names>SS</given-names></name><name><surname>Le Couteur</surname><given-names>DG</given-names></name><etal/></person-group>
<article-title>Hepatocyte entry leads to degradation of autoreactive CD8 T cells.</article-title>
<source><italic>Proc Natl Acad Sci USA.</italic></source> (<year>2011</year>) <volume>108</volume>:<fpage>16735</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1112251108</pub-id>
<pub-id pub-id-type="pmid">21933957</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Overholtzer</surname><given-names>M</given-names></name><name><surname>Mailleux</surname><given-names>AA</given-names></name><name><surname>Mouneimne</surname><given-names>G</given-names></name><name><surname>Normand</surname><given-names>G</given-names></name><name><surname>Schnitt</surname><given-names>SJ</given-names></name><name><surname>King</surname><given-names>RW</given-names></name><etal/></person-group>
<article-title>A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion.</article-title>
<source><italic>Cell.</italic></source> (<year>2007</year>) <volume>131</volume>:<fpage>966</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="pmid">18045538</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>SP</given-names></name><name><surname>Reynolds</surname><given-names>GM</given-names></name><name><surname>Wilkinson</surname><given-names>AL</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Rose</surname><given-names>R</given-names></name><name><surname>Leekha</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Hepatocytes delete regulatory T cells by enclysis, a CD4+ T cell engulfment process.</article-title>
<source><italic>Cell Rep.</italic></source> (<year>2019</year>) <volume>29</volume>:<fpage>1610</fpage>&#x02013;<lpage>20.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.09.068</pub-id>
<pub-id pub-id-type="pmid">31693899</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Misih</surname><given-names>SR</given-names></name><name><surname>Bloomston</surname><given-names>M.</given-names></name></person-group>
<article-title>Liver anatomy.</article-title>
<source><italic>Surg Clin North Am.</italic></source> (<year>2010</year>) <volume>90</volume>:<fpage>643</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.suc.2010.04.017</pub-id>
<pub-id pub-id-type="pmid">20637938</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenne</surname><given-names>CN</given-names></name><name><surname>Kubes</surname><given-names>P.</given-names></name></person-group>
<article-title>Immune surveillance by the liver.</article-title>
<source><italic>Nat Immunol.</italic></source> (<year>2013</year>) <volume>14</volume>:<fpage>996</fpage>&#x02013;<lpage>1006</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2691</pub-id>
<pub-id pub-id-type="pmid">24048121</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asrani</surname><given-names>SK</given-names></name><name><surname>Devarbhavi</surname><given-names>H</given-names></name><name><surname>Eaton</surname><given-names>J</given-names></name><name><surname>Kamath</surname><given-names>PS.</given-names></name></person-group>
<article-title>Burden of liver diseases in the world.</article-title>
<source><italic>J Hepatol.</italic></source> (<year>2019</year>) <volume>70</volume>:<fpage>151</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">30266282</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crispe</surname><given-names>IN</given-names></name><name><surname>Dao</surname><given-names>T</given-names></name><name><surname>Klugewitz</surname><given-names>K</given-names></name><name><surname>Mehal</surname><given-names>WZ</given-names></name><name><surname>Metz</surname><given-names>DP.</given-names></name></person-group>
<article-title>The liver as a site of T-cell apoptosis: graveyard, or killing field?</article-title>
<source><italic>Immunol Rev.</italic></source> (<year>2000</year>) <volume>174</volume>:<fpage>47</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="pmid">10807506</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnardel</surname><given-names>J</given-names></name><name><surname>T&#x02019;Jonck</surname><given-names>W</given-names></name><name><surname>Gaublomme</surname><given-names>D</given-names></name><name><surname>Browaeys</surname><given-names>R</given-names></name><name><surname>Scott</surname><given-names>CL</given-names></name><name><surname>Martens</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Stellate cells, hepatocytes, and endothelial cells imprint the kupffer cell identity on monocytes colonizing the liver macrophage niche.</article-title>
<source><italic>Immunity.</italic></source> (<year>2019</year>) <volume>51</volume>:<fpage>638</fpage>&#x02013;<lpage>654.e9</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2019.08.017</pub-id>
<pub-id pub-id-type="pmid">31561945</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krajcovic</surname><given-names>M</given-names></name><name><surname>Overholtzer</surname><given-names>M.</given-names></name></person-group>
<article-title>Mechanisms of ploidy increase in human cancers: a new role for cell cannibalism.</article-title>
<source><italic>Cancer Res.</italic></source> (<year>2012</year>) <volume>72</volume>:<fpage>1596</fpage>&#x02013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-3127</pub-id>
<pub-id pub-id-type="pmid">22447569</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westman</surname><given-names>J</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name><name><surname>Marques</surname><given-names>PE.</given-names></name></person-group>
<article-title>Phagocytosis of necrotic debris at sites of injury and inflammation.</article-title>
<source><italic>Front Immunol.</italic></source> (<year>2020</year>) <volume>10</volume>:<issue>3030</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.03030</pub-id>
<pub-id pub-id-type="pmid">31998312</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stocker</surname><given-names>E</given-names></name><name><surname>Heine</surname><given-names>WD.</given-names></name></person-group>
<article-title>Regeneration of liver parenchyma under normal and pathological conditions.</article-title>
<source><italic>Beitr Pathol.</italic></source> (<year>1971</year>) <volume>144</volume>:<fpage>400</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">5158468</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalopoulos</surname><given-names>GK</given-names></name><name><surname>DeFrances</surname><given-names>MC.</given-names></name></person-group>
<article-title>Liver regeneration.</article-title>
<source><italic>Science.</italic></source> (<year>1997</year>) <volume>276</volume>:<fpage>60</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="pmid">9082986</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname><given-names>TG</given-names></name><name><surname>Forbes</surname><given-names>SJ.</given-names></name></person-group>
<article-title>Two fresh streams to fill the liver&#x02019;s hepatocyte pool.</article-title>
<source><italic>Cell Stem Cell.</italic></source> (<year>2015</year>) <volume>17</volume>:<fpage>377</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2015.09.007</pub-id>
<pub-id pub-id-type="pmid">26431179</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>AW</given-names></name><name><surname>Taylor</surname><given-names>MH</given-names></name><name><surname>Hickey</surname><given-names>RD</given-names></name><name><surname>Hanlon Newell</surname><given-names>AE</given-names></name><name><surname>Lenzi</surname><given-names>ML</given-names></name><name><surname>Olson</surname><given-names>SB</given-names></name><etal/></person-group>
<article-title>The ploidy conveyor of mature hepatocytes as a source of genetic variation.</article-title>
<source><italic>Nature.</italic></source> (<year>2010</year>) <volume>467</volume>:<fpage>707</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/nature09414</pub-id>
<pub-id pub-id-type="pmid">20861837</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>AW</given-names></name><name><surname>Hanlon Newell</surname><given-names>AE</given-names></name><name><surname>Bi</surname><given-names>W</given-names></name><name><surname>Finegold</surname><given-names>MJ</given-names></name><name><surname>Olson</surname><given-names>SB</given-names></name><name><surname>Beaudet</surname><given-names>AL</given-names></name><etal/></person-group>
<article-title>Aneuploidy as a mechanism for stress-induced liver adaptation.</article-title>
<source><italic>J Clin Invest.</italic></source> (<year>2012</year>) <volume>122</volume>:<fpage>3307</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1172/JCI64026</pub-id>
<pub-id pub-id-type="pmid">22863619</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>AW.</given-names></name></person-group>
<article-title>Aneuploidy, polyploidy and ploidy reversal in the liver.</article-title>
<source><italic>Semin Cell Dev Biol.</italic></source> (<year>2013</year>) <volume>24</volume>:<fpage>347</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2013.01.003</pub-id>
<pub-id pub-id-type="pmid">23333793</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>AW</given-names></name><name><surname>Hanlon Newell</surname><given-names>AE</given-names></name><name><surname>Smith</surname><given-names>L</given-names></name><name><surname>Wilson</surname><given-names>EM</given-names></name><name><surname>Olson</surname><given-names>SB</given-names></name><name><surname>Thayer</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>Frequent aneuploidy among normal human hepatocytes.</article-title>
<source><italic>Gastroenterology.</italic></source> (<year>2012</year>) <volume>142</volume>:<fpage>25</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2011.10.029</pub-id>
<pub-id pub-id-type="pmid">22057114</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Triantafyllou</surname><given-names>E</given-names></name><name><surname>Pop</surname><given-names>OT</given-names></name><name><surname>Possamai</surname><given-names>LA</given-names></name><name><surname>Wilhelm</surname><given-names>A</given-names></name><name><surname>Liaskou</surname><given-names>E</given-names></name><name><surname>Singanayagam</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure.</article-title>
<source><italic>Gut.</italic></source> (<year>2017</year>) <volume>67</volume>:<fpage>333</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2016-313615</pub-id>
<pub-id pub-id-type="pmid">28450389</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campana</surname><given-names>L</given-names></name><name><surname>Starkey Lewis</surname><given-names>PJ</given-names></name><name><surname>Pellicoro</surname><given-names>A</given-names></name><name><surname>Aucott</surname><given-names>RL</given-names></name><name><surname>Man</surname><given-names>J</given-names></name><name><surname>O&#x02019;Duibhir</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>The STAT3-IL-10-IL-6 pathway is a novel regulator of macrophage efferocytosis and phenotypic conversion in sterile liver injury.</article-title>
<source><italic>J Immunol.</italic></source> (<year>2018</year>) <volume>200</volume>:<fpage>1169</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1701247</pub-id>
<pub-id pub-id-type="pmid">29263216</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poralla</surname><given-names>T</given-names></name><name><surname>Treichel</surname><given-names>U</given-names></name><name><surname>Lohr</surname><given-names>H</given-names></name><name><surname>Fleischer</surname><given-names>B.</given-names></name></person-group>
<article-title>The asialoglycoprotein receptor as target structure in autoimmune liver diseases.</article-title>
<source><italic>Semin Liver Dis.</italic></source> (<year>1991</year>) <volume>11</volume>:<fpage>215</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">1925646</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treichel</surname><given-names>U</given-names></name><name><surname>Gerken</surname><given-names>G</given-names></name><name><surname>Rossol</surname><given-names>S</given-names></name><name><surname>Rotthauwe</surname><given-names>HW</given-names></name><name><surname>Meyer zum Buschenfelde</surname><given-names>KH</given-names></name><name><surname>Poralla</surname><given-names>T.</given-names></name></person-group>
<article-title>Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis.</article-title>
<source><italic>J Hepatol.</italic></source> (<year>1993</year>) <volume>19</volume>:<fpage>55</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="pmid">8301043</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McVicker</surname><given-names>BL</given-names></name><name><surname>Tuma</surname><given-names>DJ</given-names></name><name><surname>Kubik</surname><given-names>JA</given-names></name><name><surname>Hindemith</surname><given-names>AM</given-names></name><name><surname>Baldwin</surname><given-names>CR</given-names></name><name><surname>Casey</surname><given-names>CA.</given-names></name></person-group>
<article-title>The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes.</article-title>
<source><italic>Hepatology (Baltimore, Md).</italic></source> (<year>2002</year>) <volume>36</volume>:<fpage>1478</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="pmid">12447874</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppe</surname><given-names>JP</given-names></name><name><surname>Desprez</surname><given-names>PY</given-names></name><name><surname>Krtolica</surname><given-names>A</given-names></name><name><surname>Campisi</surname><given-names>J.</given-names></name></person-group>
<article-title>The senescence-associated secretory phenotype: the dark side of tumor suppression.</article-title>
<source><italic>Annu Rev Pathol.</italic></source> (<year>2010</year>) <volume>5</volume>:<fpage>99</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathol-121808-102144</pub-id>
<pub-id pub-id-type="pmid">20078217</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aravinthan</surname><given-names>A.</given-names></name></person-group>
<article-title>Cellular senescence: a hitchhiker&#x02019;s guide.</article-title>
<source><italic>Hum Cell.</italic></source> (<year>2015</year>) <volume>28</volume>:<fpage>51</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1007/s13577-015-0110-x</pub-id>
<pub-id pub-id-type="pmid">25690721</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aravinthan</surname><given-names>AD</given-names></name><name><surname>Alexander</surname><given-names>GJM.</given-names></name></person-group>
<article-title>Senescence in chronic liver disease: is the future in aging?</article-title>
<source><italic>J Hepatol.</italic></source> (<year>2016</year>) <volume>65</volume>:<fpage>825</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2016.05.030</pub-id>
<pub-id pub-id-type="pmid">27245432</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baylis</surname><given-names>D</given-names></name><name><surname>Bartlett</surname><given-names>DB</given-names></name><name><surname>Patel</surname><given-names>HP</given-names></name><name><surname>Roberts</surname><given-names>HC.</given-names></name></person-group>
<article-title>Understanding how we age: insights into inflammaging.</article-title>
<source><italic>Longev Healthspan.</italic></source> (<year>2013</year>) <volume>2</volume>:<issue>8</issue>. <pub-id pub-id-type="doi">10.1186/2046-2395-2-8</pub-id>
<pub-id pub-id-type="pmid">24472098</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Fabbri</surname><given-names>E.</given-names></name></person-group>
<article-title>Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty.</article-title>
<source><italic>Nat Rev Cardiol.</italic></source> (<year>2018</year>) <volume>15</volume>:<fpage>505</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-018-0064-2</pub-id>
<pub-id pub-id-type="pmid">30065258</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aprahamian</surname><given-names>T</given-names></name><name><surname>Takemura</surname><given-names>Y</given-names></name><name><surname>Goukassian</surname><given-names>D</given-names></name><name><surname>Walsh</surname><given-names>K.</given-names></name></person-group>
<article-title>Ageing is associated with diminished apoptotic cell clearance in vivo.</article-title>
<source><italic>Clin Exp Immunol.</italic></source> (<year>2008</year>) <volume>152</volume>:<fpage>448</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2008.03658.x</pub-id>
<pub-id pub-id-type="pmid">18422728</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linehan</surname><given-names>E</given-names></name><name><surname>Dombrowski</surname><given-names>Y</given-names></name><name><surname>Snoddy</surname><given-names>R</given-names></name><name><surname>Fallon</surname><given-names>PG</given-names></name><name><surname>Kissenpfennig</surname><given-names>A</given-names></name><name><surname>Fitzgerald</surname><given-names>DC.</given-names></name></person-group>
<article-title>Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis.</article-title>
<source><italic>Aging Cell.</italic></source> (<year>2014</year>) <volume>13</volume>:<fpage>699</fpage>&#x02013;<lpage>708</lpage>.<pub-id pub-id-type="pmid">24813244</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>CK</given-names></name><name><surname>Smith</surname><given-names>CA</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Koff</surname><given-names>JL</given-names></name><name><surname>Goldstein</surname><given-names>DR.</given-names></name></person-group>
<article-title>Aging impairs alveolar macrophage phagocytosis and increases influenza-induced mortality in mice.</article-title>
<source><italic>J Immunol.</italic></source> (<year>2017</year>) <volume>199</volume>:<fpage>1060</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1700397</pub-id>
<pub-id pub-id-type="pmid">28646038</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fais</surname><given-names>S</given-names></name><name><surname>Overholtzer</surname><given-names>M.</given-names></name></person-group>
<article-title>Cell-in-cell phenomena in cancer.</article-title>
<source><italic>Nat Rev Cancer.</italic></source> (<year>2018</year>) <volume>18</volume>:<fpage>758</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1038/s41568-018-0073-9</pub-id>
<pub-id pub-id-type="pmid">30420767</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>HL</given-names></name><name><surname>Muller</surname><given-names>PAJ.</given-names></name></person-group>
<article-title>Biological relevance of cell-in-cell in cancers.</article-title>
<source><italic>Biochem Soc Trans.</italic></source> (<year>2019</year>) <volume>47</volume>:<fpage>725</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1042/BST20180618</pub-id>
<pub-id pub-id-type="pmid">30850425</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durgan</surname><given-names>J</given-names></name><name><surname>Florey</surname><given-names>O.</given-names></name></person-group>
<article-title>Cancer cell cannibalism: multiple triggers emerge for entosis.</article-title>
<source><italic>Biochim Biophys Acta Mol Cell Res.</italic></source> (<year>2018</year>) <volume>1865</volume>:<fpage>831</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2018.03.004</pub-id>
<pub-id pub-id-type="pmid">29548938</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinojosa</surname><given-names>LS</given-names></name><name><surname>Holst</surname><given-names>M</given-names></name><name><surname>Baarlink</surname><given-names>C</given-names></name><name><surname>Grosse</surname><given-names>R.</given-names></name></person-group>
<article-title>MRTF transcription and Ezrin-dependent plasma membrane blebbing are required for entotic invasion.</article-title>
<source><italic>J Cell Biol.</italic></source> (<year>2017</year>) <volume>216</volume>:<fpage>3087</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201702010</pub-id>
<pub-id pub-id-type="pmid">28774893</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purvanov</surname><given-names>V</given-names></name><name><surname>Holst</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>J</given-names></name><name><surname>Baarlink</surname><given-names>C</given-names></name><name><surname>Grosse</surname><given-names>R.</given-names></name></person-group>
<article-title>G-protein-coupled receptor signaling and polarized actin dynamics drive cell-in-cell invasion.</article-title>
<source><italic>elife.</italic></source> (<year>2014</year>) <volume>3</volume>:<issue>e02786</issue>. <pub-id pub-id-type="doi">10.7554/eLife.02786</pub-id>
<pub-id pub-id-type="pmid">24950964</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durgan</surname><given-names>J</given-names></name><name><surname>Tseng</surname><given-names>YY</given-names></name><name><surname>Hamann</surname><given-names>JC</given-names></name><name><surname>Domart</surname><given-names>MC</given-names></name><name><surname>Collinson</surname><given-names>L</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Mitosis can drive cell cannibalism through entosis.</article-title>
<source><italic>elife.</italic></source> (<year>2017</year>) <volume>6</volume>:<issue>e27134</issue>. <pub-id pub-id-type="doi">10.7554/eLife.27134</pub-id>
<pub-id pub-id-type="pmid">28693721</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Cibas</surname><given-names>ES</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Hodgson</surname><given-names>L</given-names></name><name><surname>Overholtzer</surname><given-names>M.</given-names></name></person-group>
<article-title>Induction of entosis by epithelial cadherin expression.</article-title>
<source><italic>Cell Res.</italic></source> (<year>2014</year>) <volume>24</volume>:<fpage>1288</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2014.137</pub-id>
<pub-id pub-id-type="pmid">25342558</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Cholesterol inhibits entotic cell-in-cell formation and actomyosin contraction.</article-title>
<source><italic>Biochem Biophys Res Commun.</italic></source> (<year>2018</year>) <volume>495</volume>:<fpage>1440</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.11.197</pub-id>
<pub-id pub-id-type="pmid">29198709</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florey</surname><given-names>O</given-names></name><name><surname>Kim</surname><given-names>SE</given-names></name><name><surname>Sandoval</surname><given-names>CP</given-names></name><name><surname>Haynes</surname><given-names>CM</given-names></name><name><surname>Overholtzer</surname><given-names>M.</given-names></name></person-group>
<article-title>Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes.</article-title>
<source><italic>Nat Cell Biol.</italic></source> (<year>2011</year>) <volume>13</volume>:<fpage>1335</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2363</pub-id>
<pub-id pub-id-type="pmid">22002674</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florey</surname><given-names>O</given-names></name><name><surname>Krajcovic</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Overholtzer</surname><given-names>M.</given-names></name></person-group>
<article-title>Entosis.</article-title>
<source><italic>Curr Biol.</italic></source> (<year>2010</year>) <volume>20</volume>:<fpage>R88</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">20144773</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>HL</given-names></name><name><surname>Moore</surname><given-names>D</given-names></name><name><surname>Hall</surname><given-names>C</given-names></name><name><surname>Birkbak</surname><given-names>NJ</given-names></name><name><surname>Jamal-Hanjani</surname><given-names>M</given-names></name><name><surname>Karim</surname><given-names>SA</given-names></name><etal/></person-group>
<article-title>Genomic instability in mutant p53 cancer cells upon entotic engulfment.</article-title>
<source><italic>Nat Commun.</italic></source> (<year>2018</year>) <volume>9</volume>:<issue>3070</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-05368-1</pub-id>
<pub-id pub-id-type="pmid">30076358</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname><given-names>S</given-names></name><name><surname>Overholtzer</surname><given-names>M.</given-names></name></person-group>
<article-title>Mechanisms and consequences of entosis.</article-title>
<source><italic>Cell Mol Life Sci.</italic></source> (<year>2016</year>) <volume>73</volume>:<fpage>2379</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-016-2207-0</pub-id>
<pub-id pub-id-type="pmid">27048820</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fais</surname><given-names>S.</given-names></name></person-group>
<article-title>Cannibalism: a way to feed on metastatic tumors.</article-title>
<source><italic>Cancer Lett.</italic></source> (<year>2007</year>) <volume>258</volume>:<fpage>155</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="pmid">17977647</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>JC</given-names></name><name><surname>Surcel</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Teragawa</surname><given-names>C</given-names></name><name><surname>Albeck</surname><given-names>JG</given-names></name><name><surname>Robinson</surname><given-names>DN</given-names></name><etal/></person-group>
<article-title>Entosis is induced by glucose starvation.</article-title>
<source><italic>Cell Rep.</italic></source> (<year>2017</year>) <volume>20</volume>:<fpage>201</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.06.037</pub-id>
<pub-id pub-id-type="pmid">28683313</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Florey</surname><given-names>O</given-names></name><name><surname>Shirasawa</surname><given-names>S</given-names></name><name><surname>Sasazuki</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Competition between human cells by entosis.</article-title>
<source><italic>Cell Res.</italic></source> (<year>2014</year>) <volume>24</volume>:<fpage>1299</fpage>&#x02013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2014.138</pub-id>
<pub-id pub-id-type="pmid">25342560</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrick</surname><given-names>JL</given-names></name><name><surname>Kelly</surname><given-names>SP</given-names></name><name><surname>Altekruse</surname><given-names>SF</given-names></name><name><surname>McGlynn</surname><given-names>KA</given-names></name><name><surname>Rosenberg</surname><given-names>PS.</given-names></name></person-group>
<article-title>Future of hepatocellular carcinoma incidence in the united states forecast through 2030.</article-title>
<source><italic>J Clin Oncol.</italic></source> (<year>2016</year>) <volume>34</volume>:<fpage>1787</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">27044939</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humble</surname><given-names>JG</given-names></name><name><surname>Jayne</surname><given-names>WH</given-names></name><name><surname>Pulvertaft</surname><given-names>RJ.</given-names></name></person-group>
<article-title>Biological interaction between lymphocytes and other cells.</article-title>
<source><italic>Br J Haematol.</italic></source> (<year>1956</year>) <volume>2</volume>:<fpage>283</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">13342362</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>Q</given-names></name><name><surname>Bian</surname><given-names>Z</given-names></name><name><surname>Tang</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis.</article-title>
<source><italic>Clin Rev Allergy Immunol.</italic></source> (<year>2015</year>) <volume>48</volume>:<fpage>226</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1007/s12016-014-8432-0</pub-id>
<pub-id pub-id-type="pmid">25051956</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Kakuda</surname><given-names>Y</given-names></name><name><surname>Harada</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><name><surname>Ikeda</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis.</article-title>
<source><italic>World J Gastroenterol.</italic></source> (<year>2014</year>) <volume>20</volume>:<fpage>3597</fpage>&#x02013;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v20.i13.3597</pub-id>
<pub-id pub-id-type="pmid">24707143</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dienes</surname><given-names>HP.</given-names></name></person-group>
<article-title>Viral and autoimmune hepatitis. Morphologic and pathogenetic aspects of cell damage in hepatitis with potential chronicity.</article-title>
<source><italic>Veroff Pathol.</italic></source> (<year>1989</year>) <volume>132</volume>:<fpage>1</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="pmid">2524940</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avci</surname><given-names>Z</given-names></name><name><surname>Turul</surname><given-names>T</given-names></name><name><surname>Catal</surname><given-names>F</given-names></name><name><surname>Olgar</surname><given-names>S</given-names></name><name><surname>Baykan</surname><given-names>A</given-names></name><name><surname>Tekfam</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Thrombocytopenia and emperipolesis in a patient with hepatitis a infection.</article-title>
<source><italic>Pediatr Hematol Oncol.</italic></source> (<year>2002</year>) <volume>19</volume>:<fpage>67</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="pmid">11787869</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aizawa</surname><given-names>S</given-names></name><name><surname>Brar</surname><given-names>G</given-names></name><name><surname>Tsukamoto</surname><given-names>H.</given-names></name></person-group>
<article-title>Cell death and liver disease.</article-title>
<source><italic>Gut Liver.</italic></source> (<year>2019</year>) <volume>14</volume>:<fpage>20</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierro</surname><given-names>F</given-names></name><name><surname>Tay</surname><given-names>SS</given-names></name><name><surname>Warren</surname><given-names>A</given-names></name><name><surname>Le Couteur</surname><given-names>DG</given-names></name><name><surname>McCaughan</surname><given-names>GW</given-names></name><name><surname>Bowen</surname><given-names>DG</given-names></name><etal/></person-group>
<article-title>Suicidal emperipolesis: a process leading to cell-in-cell structures, T cell clearance and immune homeostasis.</article-title>
<source><italic>Curr Mol Med.</italic></source> (<year>2015</year>) <volume>15</volume>:<fpage>819</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">26511707</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordon</surname><given-names>Y.</given-names></name></person-group>
<article-title>Immune tolerance: suicide is painless.</article-title>
<source><italic>Nat Rev Immunol.</italic></source> (<year>2011</year>) <volume>11</volume>:<issue>719</issue>.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Xia</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Internalization of NK cells into tumor cells requires ezrin and leads to programmed cell-in-cell death.</article-title>
<source><italic>Cell Res.</italic></source> (<year>2009</year>) <volume>19</volume>:<fpage>1350</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2009.114</pub-id>
<pub-id pub-id-type="pmid">19786985</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>MF</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>MY</given-names></name><name><surname>Yu</surname><given-names>XM</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Rapid reuptake of granzyme B leads to emperitosis: an apoptotic cell-in-cell death of immune killer cells inside tumor cells.</article-title>
<source><italic>Cell Death Dis.</italic></source> (<year>2013</year>) <volume>4</volume>:<issue>e856</issue>. <pub-id pub-id-type="doi">10.1038/cddis.2013.352</pub-id>
<pub-id pub-id-type="pmid">24113190</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Otani</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>F</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Kibata</surname><given-names>M.</given-names></name></person-group>
<article-title>Cell-in-cell structures formed between human cancer cell lines and the cytotoxic regulatory T-cell line HOZOT.</article-title>
<source><italic>J Mol Cell Biol.</italic></source> (<year>2010</year>) <volume>2</volume>:<fpage>139</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1093/jmcb/mjq002</pub-id>
<pub-id pub-id-type="pmid">20348186</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-beta-dependent emperipolesis in HBV cirrhotic patients.</article-title>
<source><italic>Sci Rep.</italic></source> (<year>2017</year>) <volume>7</volume>:<issue>44544</issue>. <pub-id pub-id-type="doi">10.1038/srep44544</pub-id>
<pub-id pub-id-type="pmid">28291251</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>J</given-names></name><name><surname>Helenius</surname><given-names>A.</given-names></name></person-group>
<article-title>Virus entry by macropinocytosis.</article-title>
<source><italic>Nat Cell Biol.</italic></source> (<year>2009</year>) <volume>11</volume>:<fpage>510</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1038/ncb0509-510</pub-id>
<pub-id pub-id-type="pmid">19404330</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horst</surname><given-names>AK</given-names></name><name><surname>Neumann</surname><given-names>K</given-names></name><name><surname>Diehl</surname><given-names>L</given-names></name><name><surname>Tiegs</surname><given-names>G.</given-names></name></person-group>
<article-title>Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells.</article-title>
<source><italic>Cell Mol Immunol.</italic></source> (<year>2016</year>) <volume>13</volume>:<fpage>277</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1038/cmi.2015.112</pub-id>
<pub-id pub-id-type="pmid">27041638</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>BD</given-names></name><name><surname>King</surname><given-names>LS</given-names></name><name><surname>D&#x02019;Alessio</surname><given-names>FR.</given-names></name></person-group>
<article-title>Regulatory T cells as immunotherapy.</article-title>
<source><italic>Front Immunol.</italic></source> (<year>2014</year>) <volume>5</volume>:<issue>46</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2014.00046</pub-id>
<pub-id pub-id-type="pmid">24575095</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bluestone</surname><given-names>JA</given-names></name><name><surname>Tang</surname><given-names>Q.</given-names></name></person-group>
<article-title>Treg cells-the next frontier of cell therapy.</article-title>
<source><italic>Science.</italic></source> (<year>2018</year>) <volume>362</volume>:<fpage>154</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">30309932</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esensten</surname><given-names>JH</given-names></name><name><surname>Muller</surname><given-names>YD</given-names></name><name><surname>Bluestone</surname><given-names>JA</given-names></name><name><surname>Tang</surname><given-names>Q.</given-names></name></person-group>
<article-title>Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier.</article-title>
<source><italic>J Allergy Clin Immunol.</italic></source> (<year>2018</year>) <volume>142</volume>:<fpage>1710</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2018.10.015</pub-id>
<pub-id pub-id-type="pmid">30367909</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>LMR</given-names></name><name><surname>Muller</surname><given-names>YD</given-names></name><name><surname>Bluestone</surname><given-names>JA</given-names></name><name><surname>Tang</surname><given-names>Q.</given-names></name></person-group>
<article-title>Next-generation regulatory T cell therapy.</article-title>
<source><italic>Nat Rev Drug Discov.</italic></source> (<year>2019</year>) <volume>18</volume>:<fpage>749</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1038/s41573-019-0041-4</pub-id>
<pub-id pub-id-type="pmid">31541224</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>HC</given-names></name><name><surname>Braitch</surname><given-names>MK</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name><name><surname>Oo</surname><given-names>YH.</given-names></name></person-group>
<article-title>Clinical potential of regulatory T cell therapy in liver diseases: an overview and current perspectives.</article-title>
<source><italic>Front Immunol.</italic></source> (<year>2016</year>) <volume>7</volume>:<issue>334</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2016.00334</pub-id>
<pub-id pub-id-type="pmid">27656181</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azimi</surname><given-names>CS</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Roybal</surname><given-names>KT</given-names></name><name><surname>Bluestone</surname><given-names>JA.</given-names></name></person-group>
<article-title>NextGen cell-based immunotherapies in cancer and other immune disorders.</article-title>
<source><italic>Curr Opin Immunol.</italic></source> (<year>2019</year>) <volume>59</volume>:<fpage>79</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2019.03.007</pub-id>
<pub-id pub-id-type="pmid">31071513</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krajcovic</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>NB</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Normand</surname><given-names>G</given-names></name><name><surname>Hoover</surname><given-names>N</given-names></name><name><surname>Yao</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>A non-genetic route to aneuploidy in human cancers.</article-title>
<source><italic>Nat Cell Biol.</italic></source> (<year>2011</year>) <volume>13</volume>:<fpage>324</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2174</pub-id>
<pub-id pub-id-type="pmid">21336303</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YH</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Mice with increased numbers of polyploid hepatocytes maintain regenerative capacity but develop fewer tumors following chronic liver injury.</article-title>
<source><italic>Gastroenterology.</italic></source> (<year>2020</year>). (<comment>in press</comment>). <pub-id pub-id-type="doi">10.1053/j.gastro.2020.01.026</pub-id>
<pub-id pub-id-type="pmid">31972235</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abodief</surname><given-names>WT</given-names></name><name><surname>Dey</surname><given-names>P</given-names></name><name><surname>Al-Hattab</surname><given-names>O.</given-names></name></person-group>
<article-title>Cell cannibalism in ductal carcinoma of breast.</article-title>
<source><italic>Cytopathology.</italic></source> (<year>2006</year>) <volume>17</volume>:<fpage>304</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">16961662</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>AW</given-names></name><name><surname>Hickey</surname><given-names>RD</given-names></name><name><surname>Paulk</surname><given-names>NK</given-names></name><name><surname>Culberson</surname><given-names>AJ</given-names></name><name><surname>Olson</surname><given-names>SB</given-names></name><name><surname>Finegold</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>Ploidy reductions in murine fusion-derived hepatocytes.</article-title>
<source><italic>PLoS Genet.</italic></source> (<year>2009</year>) <volume>5</volume>:<issue>e1000385</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000385</pub-id>
<pub-id pub-id-type="pmid">19229314</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>PD</given-names></name><name><surname>Delgado</surname><given-names>ER</given-names></name><name><surname>Alencastro</surname><given-names>F</given-names></name><name><surname>Leek</surname><given-names>MP</given-names></name><name><surname>Roy</surname><given-names>N</given-names></name><name><surname>Weirich</surname><given-names>MP</given-names></name><etal/></person-group>
<article-title>The polyploid state restricts hepatocyte proliferation and liver regeneration in mice.</article-title>
<source><italic>Hepatology.</italic></source> (<year>2019</year>) <volume>69</volume>:<fpage>1242</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1002/hep.30286</pub-id>
<pub-id pub-id-type="pmid">30244478</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>PD</given-names></name><name><surname>Alencastro</surname><given-names>F</given-names></name><name><surname>Delgado</surname><given-names>ER</given-names></name><name><surname>Leek</surname><given-names>MP</given-names></name><name><surname>Weirich</surname><given-names>MP</given-names></name><name><surname>Otero</surname><given-names>PA</given-names></name><etal/></person-group>
<article-title>Polyploid hepatocytes facilitate adaptation and regeneration to chronic liver injury.</article-title>
<source><italic>Am J Pathol.</italic></source> (<year>2019</year>) <volume>189</volume>:<fpage>1241</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2019.02.008</pub-id>
<pub-id pub-id-type="pmid">30928253</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>MJ</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Lau</surname><given-names>JTY</given-names></name><name><surname>Hu</surname><given-names>YP.</given-names></name></person-group>
<article-title>Hepatocyte polyploidization and its association with pathophysiological processes.</article-title>
<source><italic>Cell Death Dis.</italic></source> (<year>2017</year>) <volume>8</volume>:<issue>e2805</issue>. <pub-id pub-id-type="doi">10.1038/cddis.2017.167</pub-id>
<pub-id pub-id-type="pmid">28518148</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentric</surname><given-names>G</given-names></name><name><surname>Maillet</surname><given-names>V</given-names></name><name><surname>Paradis</surname><given-names>V</given-names></name><name><surname>Couton</surname><given-names>D</given-names></name><name><surname>L&#x02019;Hermitte</surname><given-names>A</given-names></name><name><surname>Panasyuk</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.</article-title>
<source><italic>J Clin Invest.</italic></source> (<year>2015</year>) <volume>125</volume>:<fpage>981</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1172/JCI73957</pub-id>
<pub-id pub-id-type="pmid">25621497</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwabe</surname><given-names>RF</given-names></name><name><surname>Luedde</surname><given-names>T.</given-names></name></person-group>
<article-title>Apoptosis and necroptosis in the liver: a matter of life and death.</article-title>
<source><italic>Nat Rev Gastroenterol Hepatol.</italic></source> (<year>2018</year>) <volume>15</volume>:<fpage>738</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/s41575-018-0065-y</pub-id>
<pub-id pub-id-type="pmid">30250076</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luedde</surname><given-names>T</given-names></name><name><surname>Kaplowitz</surname><given-names>N</given-names></name><name><surname>Schwabe</surname><given-names>RF.</given-names></name></person-group>
<article-title>Cell death and cell death responses in liver disease: mechanisms and clinical relevance.</article-title>
<source><italic>Gastroenterology.</italic></source> (<year>2014</year>) <volume>147</volume>:<fpage>765</fpage>&#x02013;<lpage>783.e4</lpage>.<pub-id pub-id-type="pmid">25046161</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sommerfeld</surname><given-names>MR</given-names></name><name><surname>Jahn-Hofmann</surname><given-names>K</given-names></name><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Filliol</surname><given-names>A</given-names></name><name><surname>Remotti</surname><given-names>HE</given-names></name><etal/></person-group>
<article-title>RNA targeting hepatocyte TAZ prevents and reverses fibrosis in nonalcoholic steatohepatitis in mice.</article-title>
<source><italic>Hepatol Commun.</italic></source> (<year>2019</year>) <volume>3</volume>:<fpage>1221</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1002/hep4.1405</pub-id>
<pub-id pub-id-type="pmid">31497743</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Caviglia</surname><given-names>JM</given-names></name><name><surname>Corey</surname><given-names>KE</given-names></name><name><surname>Herfel</surname><given-names>TM</given-names></name><name><surname>Cai</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis.</article-title>
<source><italic>Cell Metab.</italic></source> (<year>2016</year>) <volume>24</volume>:<fpage>848</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.09.016</pub-id>
<pub-id pub-id-type="pmid">28068223</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Bartolome</surname><given-names>A</given-names></name><name><surname>Salomao</surname><given-names>M</given-names></name><name><surname>Dongiovanni</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.</article-title>
<source><italic>Sci Transl Med.</italic></source> (<year>2018</year>) <volume>10</volume>:<issue>eaat0344</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aat0344</pub-id>
<pub-id pub-id-type="pmid">30463916</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwabe</surname><given-names>RF</given-names></name><name><surname>Tabas</surname><given-names>I</given-names></name><name><surname>Pajvani</surname><given-names>UB.</given-names></name></person-group>
<article-title>Mechanisms of fibrosis development in NASH.</article-title>
<source><italic>Gastroenterology.</italic></source> (<year>2020</year>). (<comment>in press</comment>).</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Kesarwala</surname><given-names>AH</given-names></name><name><surname>Eggert</surname><given-names>T</given-names></name><name><surname>Medina-Echeverz</surname><given-names>J</given-names></name><name><surname>Kleiner</surname><given-names>DE</given-names></name><name><surname>Jin</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.</article-title>
<source><italic>Nature.</italic></source> (<year>2016</year>) <volume>531</volume>:<fpage>253</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nature16969</pub-id>
<pub-id pub-id-type="pmid">26934227</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wekerle</surname><given-names>H</given-names></name><name><surname>Ketelsen</surname><given-names>UP</given-names></name><name><surname>Ernst</surname><given-names>M.</given-names></name></person-group>
<article-title>Thymic nurse cells. Lymphoepithelial cell complexes in murine thymuses: morphological and serological characterization.</article-title>
<source><italic>J Exp Med.</italic></source> (<year>1980</year>) <volume>151</volume>:<fpage>925</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="pmid">6966312</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>TE.</given-names></name></person-group>
<article-title>Emperipolesis of granular leukocytes within megakaryocytes in human hemopoietic bone marrow.</article-title>
<source><italic>Am J Clin Pathol.</italic></source> (<year>1970</year>) <volume>53</volume>:<fpage>485</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">5444722</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fond</surname><given-names>AM</given-names></name><name><surname>Ravichandran</surname><given-names>KS.</given-names></name></person-group>
<article-title>Clearance of dying cells by phagocytes: mechanisms and implications for disease pathogenesis.</article-title>
<source><italic>Adv Exp Med Biol.</italic></source> (<year>2016</year>) <volume>930</volume>:<fpage>25</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-39406-0_2</pub-id>
<pub-id pub-id-type="pmid">27558816</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwegler</surname><given-names>M</given-names></name><name><surname>Wirsing</surname><given-names>AM</given-names></name><name><surname>Dollinger</surname><given-names>AJ</given-names></name><name><surname>Abendroth</surname><given-names>B</given-names></name><name><surname>Putz</surname><given-names>F</given-names></name><name><surname>Fietkau</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Clearance of primary necrotic cells by non-professional phagocytes.</article-title>
<source><italic>Biol Cell.</italic></source> (<year>2015</year>) <volume>107</volume>:<fpage>372</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1111/boc.201400090</pub-id>
<pub-id pub-id-type="pmid">26032600</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Dey</surname><given-names>SK.</given-names></name></person-group>
<article-title>Entosis allows timely elimination of the luminal epithelial barrier for embryo implantation.</article-title>
<source><italic>Cell Rep.</italic></source> (<year>2015</year>) <volume>11</volume>:<fpage>358</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.035</pub-id>
<pub-id pub-id-type="pmid">25865893</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canton</surname><given-names>J.</given-names></name></person-group>
<article-title>Macropinocytosis: new insights into its underappreciated role in innate immune cell surveillance.</article-title>
<source><italic>Front Immunol.</italic></source> (<year>2018</year>) <volume>9</volume>:<issue>2286</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.02286</pub-id>
<pub-id pub-id-type="pmid">30333835</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunin</surname><given-names>P</given-names></name><name><surname>Bouslama</surname><given-names>R</given-names></name><name><surname>Machlus</surname><given-names>KR</given-names></name><name><surname>Martinez-Bonet</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>PY</given-names></name><name><surname>Wactor</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets.</article-title>
<source><italic>eLife.</italic></source> (<year>2019</year>) <volume>8</volume>:<issue>e44031</issue>. <pub-id pub-id-type="doi">10.7554/eLife.44031</pub-id>
<pub-id pub-id-type="pmid">31042146</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendrix</surname><given-names>TM</given-names></name><name><surname>Chilukuri</surname><given-names>RVE</given-names></name><name><surname>Martinez</surname><given-names>M</given-names></name><name><surname>Olushoga</surname><given-names>Z</given-names></name><name><surname>Blake</surname><given-names>A</given-names></name><name><surname>Brohi</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Thymic nurse cells exhibit epithelial progenitor phenotype and create unique extra-cytoplasmic membrane space for thymocyte selection.</article-title>
<source><italic>Cell Immunol.</italic></source> (<year>2010</year>) <volume>261</volume>:<fpage>81</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellimm.2009.11.004</pub-id>
<pub-id pub-id-type="pmid">20035931</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>O</given-names></name><name><surname>Kelly</surname><given-names>F</given-names></name><name><surname>Benitez</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Parker</surname><given-names>M</given-names></name><name><surname>Martinez</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>The identification of thymic nurse cells in vivo and the role of cytoskeletal proteins in thymocyte internalization.</article-title>
<source><italic>Cell Immunol.</italic></source> (<year>2004</year>) <volume>228</volume>:<fpage>119</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="pmid">15219463</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>MA</given-names></name><name><surname>Bretscher</surname><given-names>MS</given-names></name><name><surname>Watts</surname><given-names>C.</given-names></name></person-group>
<article-title>Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells.</article-title>
<source><italic>J Cell Biol.</italic></source> (<year>1989</year>) <volume>109</volume>:<fpage>2731</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">2556406</pub-id></mixed-citation></ref></ref-list></back></article>